These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 152061)

  • 1. The effect of oral contraceptive treatment on the serum concentration of dehydroisoandrosterone sulfate.
    Madden JD; Milewich L; Parker CR; Carr BR; Boyar RM; Mac Donald PC
    Am J Obstet Gynecol; 1978 Oct; 132(4):380-4. PubMed ID: 152061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate.
    Klove KL; Roy S; Lobo RA
    Contraception; 1984 Apr; 29(4):319-24. PubMed ID: 6235099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenocortical function studies during the normal menstrual cycle and in women receiving norethindrone with and without mestranol.
    Beck RP; Morcos F; Fawcett D; Watanabe M
    Am J Obstet Gynecol; 1972 Feb; 112(3):364-8. PubMed ID: 5060381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenocortical function of patients using oral contraceptives.
    Kauppila A; Järvinen PA; Ylöstalo P; Reinilä M
    Acta Obstet Gynecol Scand; 1974; 53(2):155-9. PubMed ID: 4362662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral contraceptives on plasma androgenic steroids and their precursors.
    Fern M; Rose DP; Fern EB
    Obstet Gynecol; 1978 May; 51(5):541-4. PubMed ID: 148599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
    Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the effects of oestradiol, progesterone and some steroidal contraceptives on the adrenal cortex of albino rats.
    Zaki K; Sami GE; Wassef SA; Nour H; Hassan AA
    Egypt Popul Fam Plann Rev; 1973 Jun; 6(1):33-50. PubMed ID: 12257875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of the effect of oral contraceptives containing 50 microgram of estrogen and those containing 20 microgram of estrogen on adrenal cortical function.
    Amin ES; El-Sayed MM; El-Gamel BA; Nayel SA
    Am J Obstet Gynecol; 1980 Aug; 137(7):831-3. PubMed ID: 7405974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid contraceptives in non-human primates (II). Metabolic fate of synthetic estrogens in the baboon after exposure to oral contraceptives.
    Kulkarni BD; Avila TD; O'Leary JA
    Contraception; 1977 Mar; 15(3):307-17. PubMed ID: 880810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative study of the pregnancy zone protein in sera of woman taking oral contraceptives.
    Damber MG; von Schoultz B; Solheim F; Stigbrand T
    Am J Obstet Gynecol; 1976 Feb; 124(3):289-92. PubMed ID: 55075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The measurement of arterial smooth muscle cell mitogens in the blood of oral contraceptive users.
    Bagdade JD; Subbaiah PV; Hintz RL; Wilson DM
    Atherosclerosis; 1985 Aug; 56(2):149-55. PubMed ID: 2934071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of influence of the phase of estrus cycle or treatment with steroid contraceptive drugs on cholinergic parameters in mouse and rat brain.
    Ladinsky H; Consolo S; Bianchi S; Peri G; Garattini S
    Pharmacology; 1976; 14(3):232-9. PubMed ID: 986656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of the binding capacity of plasma testosterone-estradiol-binding globulin to norethindrone, 2 mg., and mestranol, 0.1 mg., in polycystic ovarian disease.
    Andersen RN; Givens JR; Wiser WL; Umstot ES
    Am J Obstet Gynecol; 1976 May; 125(2):166-9. PubMed ID: 944533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives and ascorbic acid.
    Rivers JM
    Am J Clin Nutr; 1975 May; 28(5):550-4. PubMed ID: 1093379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives.
    Sinofsky FE; Pasquale SA
    Am J Obstet Gynecol; 1998 Feb; 178(2):300-4. PubMed ID: 9500490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I; Zaki K; Rashad S
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.